Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · ACM Research (ACMR)

ACM Research appoints Charles Pappis to board and Audit Committee effective March 15, 2025

Neutral Impact 2 of 5 leadership Written later

ACM Research added Charles Pappis, a semiconductor industry executive, to its Board of Directors and Audit Committee, effective March 15, 2025, expanding the board to five members. The filing describes a routine governance change with no financial results reported, and the company says the addition supports its plans to expand in the U.S. and into markets beyond mainland China.

Key points

  • Pappis was granted an option to purchase 10,000 Class A common shares on March 15, 2025, with an exercise price of $29.18, the Nasdaq closing price on March 14, 2025.
  • The option vests in full immediately before the 2025 Annual Meeting of Stockholders, subject to certain conditions.
  • Pappis, age 64, is President of Pappis Consulting and previously spent more than 30 years at a major U.S.-based semiconductor equipment company.
  • The board now has five members, according to a press release dated March 18, 2025.

The filing

CompanyACM Research (ACMR)
Form8-K, current report
Filed with the SECMar 18, 2025, 4:20 PM ET
Accession number0001140361-25-009270

Items reported: 5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 18, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.